Cargando…
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
Tuberculosis (TB) causes millions of deaths every year, ranking as one of the most dangerous infectious diseases worldwide. Because several pathogenic strains of Mycobacterium tuberculosis (Mtb) have developed resistance against most of the established anti-TB drugs, new therapeutic options are urge...
Autores principales: | Mori, Matteo, Stelitano, Giovanni, Chiarelli, Laurent R., Cazzaniga, Giulia, Gelain, Arianna, Barlocco, Daniela, Pini, Elena, Meneghetti, Fiorella, Villa, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918538/ https://www.ncbi.nlm.nih.gov/pubmed/33668554 http://dx.doi.org/10.3390/ph14020155 |
Ejemplares similares
-
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
por: Chiarelli, Laurent R., et al.
Publicado: (2019) -
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies
por: Pini, Elena, et al.
Publicado: (2018) -
Shedding X-ray Light on the Role of Magnesium
in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
por: Mori, Matteo, et al.
Publicado: (2020) -
Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery
por: Mori, Matteo, et al.
Publicado: (2023) -
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
por: Mori, Matteo, et al.
Publicado: (2022)